Giloralimab (Anti-TNFRSF5 / CD40)
Giloralimab (Anti-TNFRSF5 / CD40) is an agonistic monoclonal antibody directed against the B-cell surface antigen CD40 with potential antineoplastic activity. MW: 145.26 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2884 |
| Sku # | A2884-1mg*5 |
| Pricing | 1mg*5, $1690.00 |